Results 1 to 10 of about 39 (39)
Cilostazol in patients with heart failure and preserved ejection fraction—The CLIP‐HFpEF trial
• Cilostazol is an oral PDE‐3 inhibitor that may have advantageous effects in heart failure with preserved ejection fraction (HFpEF). • Cilostazol significantly improved short‐term heart failure‐related health status scores (KCCQ‐12) and NT‐proBNP levels when compared to placebo.
Norman Aiad +9 more
wiley +1 more source
Initial V‐A ECMO Flow‐Index and Its Association With Inflammation, Organ Failure, and Outcomes
Higher initial V‐A ECMO flow‐index was associated with greater shock severity and independently associated with multi‐organ failure. Early hemolysis may partly contribute to this association, particularly in eCPR patients, whereas no significant indirect effect through IL‐6 was observed.
Kostiantyn Kozakov +9 more
wiley +1 more source
Patients with a higher pre‐implant “I Need Help” score had worse unadjusted survival after LVAD implantation, but this association was attenuated after adjustment. The score may reflect the cumulative burden of advanced HF features, although its independent prognostic value in LVAD recipients remains uncertain.
Naoki Arima +14 more
wiley +1 more source
Cold septic shock: recognising the low‐output phenotype
Abstract Septic shock is commonly taught as a warm, vasodilated state, but the cold, low‐output phenotype, in which the underlying process is still sepsis but cardiac output is low and vascular resistance high, is under‐recognised. Escalating vasopressors alone in these patients support the blood pressure while leaving the low output untreated.
Prashant Maan
wiley +1 more source
Timing of Cardiac Contractility Modulation Therapy Implementation
In this retrospective registry analysis, cardiac contractility modulation (CCM) improved functional status and left ventricular ejection fraction whether implanted early or later. Implantation within 12 months after CCM‐eligible heart failure diagnosis might be associated with better survival, greater ejection‐fraction improvement, and fewer heart ...
Goekhan Yuecel +12 more
wiley +1 more source
Lung‐Cardiovascular Interactions and Derangements in ARDS
This review proposes an anatomical near‐ and far‐field framework for lung‐cardiovascular interactions in ARDS. Grounded in pathological and biological studies, the evidence spans pulmonary vascular, right ventricular, and systemic endothelial derangements and reviews available evidence for targeted therapies.
Pablo A. Sanchez +4 more
wiley +1 more source
Salvage Use of Sotatercept for Potts Shunt in Refractory Pulmonary Hypertension
ABSTRACT The reverse Potts shunt (RPS) is a promising palliative intervention for pediatric patients with drug‐refractory severe pulmonary arterial hypertension (PAH), yet it carries substantial risks of perioperative mortality and hemodynamic instability. We report two high‐risk pediatric female patients who developed acute hemodynamic instability and
Zhuoyuan Xu +8 more
wiley +1 more source
ABSTRACT Background Delirium is clinically classified into hypoactive or hyperactive motoric subtypes, which may have different responses to treatment. We assessed heterogeneity in treatment effects according to baseline motoric subtype in the AID‐ICU trial, which randomised adult ICU patients with delirium to haloperidol versus placebo.
Nina C. Andersen‐Ranberg +20 more
wiley +1 more source
This study is a comprehensive post‐market analysis of the Xenios console and XLung kit 230 preconfigured ECMO tubing set in post‐cardiotomy applications. The performance of this device was evaluated and demonstrated in all key clinical areas, with an adequate safety profile.
Luca Conci +9 more
wiley +1 more source
Clinical and translational readiness of IL‐6 measurement in HFrEF. ABSTRACT Background Interleukin‐6 (IL‐6) is frequently measured in heart failure with reduced ejection fraction (HFrEF), but its clinical utility remains unclear. Objectives To assess IL‐6 as a biomarker in HFrEF, with emphasis on the effect of treatments (pharmacodynamics) and ...
Yongxin Ye +11 more
wiley +1 more source

